Calcium intake and risk of primary hyperparathyroidism in women: Prospective cohort study

BMJ (Online)

Volumn 345, Issue 7880, 2012, Pages

  Paik, Julie M ^a   Curhan, Gary C ^a,b   Taylor, Eric N ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM;

ADULT; AGED; ARTICLE; CALCIUM INTAKE; COHORT ANALYSIS; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; NUTRITIONAL ASSESSMENT; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; WOMEN'S HEALTH;

ADULT; AGE DISTRIBUTION; AGED; BODY MASS INDEX; BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; DIETARY SUPPLEMENTS; FEMALE; HEALTH STATUS; HUMANS; HYPERTHYROIDISM; INCIDENCE; MIDDLE AGED; NURSES; PARATHYROID HORMONE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84868025822     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.e6390     Document Type: Article

References (42)

1. Marcocci C, Cetani F. Clinical practice. Primary hyperparathyroidism. N Engl J Med 2011; 365:2389-97.
2. NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement. Ann Intern Med 1991; 114:593-7.
3. Jorde R, Bonaa KH, Sundsfjord J. Primary hyperparathyroidism detected in a health screening: the Tromso study. J Clin Epidemiol 2000; 53:1164-9.
4. Lundgren E, Hagstrom EG, Lundin J, Winnerback K, Roos J, Ljunghall S, et al. Primary hyperparathyroidism revisited in menopausal women with serum calcium in the upper normal range at population-based screening 8 years ago. World J Surg 2002; 26:931-6.
5. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg 2005; 132:359-72.
6. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997; 126:433-40.
7. Rubin MR, Bilezikian JP, McMahon DJ, Jacobs T, Shane E, Siris E, et al. The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years. J Clin Endocrinol Metab 2008; 93:3462-70.
8. Silverberg S, Shane E, Jacobs T, Siris E, Bilezikian J. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341:1249-55.
9. Bilezikian J, Silverberg S. Clinical spectrum of primary hyperparathyroidism. Rev Endocr Metab Disord 2000; 1:237-45.
10. Arnold A, Kim HG, Gaz RD, Eddy RL, Fukushima Y, Byers MG, et al. Molecular cloning and chromosomal mapping of DNA rearranged with the parathyroid hormone gene in a parathyroid adenoma. J Clin Invest 1989; 83:2034-40.
11. Miedlich S, Krohn K, Paschke R. Update on genetic and clinical aspects of primary hyperparathyroidism. Clin Endocrinol (Oxf) 2003; 59:539-54.
12. Beard CM, Heath H 3rd, O'Fallon WM, Anderson JA, Earle JD, Melton LJ 3rd. Therapeutic radiation and hyperparathyroidism. A case-control study in Rochester, Minn. Arch Intern Med 1989; 149:1887-90.
13. Arnold A, Staunton CE, Kim HG, Gaz RD, Kronenberg HM. Monoclonality and abnormal parathyroid hormone genes in parathyroid adenomas. N Engl J Med 1988; 318:658-62.
14. Shan L, Nakamura M, Nakamura Y, Inoue D, Morimoto S, Yokoi T, et al. Comparative analysis of clonality and pathology in primary and secondary hyperparathyroidism. Virchows Arch 1997; 430:247-51.
15. Miedlich S, Krohn K, Lamesch P, Muller A, Paschke R. Frequency of somatic MEN1 gene mutations in monoclonal parathyroid tumours of patients with primary hyperparathyroidism. Eur J Endocrinol 2000; 143:47-54.
16. Arnold A, Brown M, Ureña P, Gaz R, Sarfati E, Drüeke T. Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 1995; 95:2047-53.
17. McKane WR, Khosla S, Egan KS, Robins SP, Burritt MF, Riggs BL. Role ofcalcium intake in modulating age-related increases in parathyroid function and bone resorption. J Clin Endocrinol Metab 1996; 81:1699-703.
18. Tordoff M, Hughes R, Pilchak D. Calcium intake by rats: influence of parathyroid hormone, calcitonin, and 1,25-dihydroxyvitamin D. Am J Physiol 1998; 274:R214-31.
19. Naveh-Many T, Friedlaender M, Mayer H, Silver J. Calcium regulates parathyroid hormone messenger ribonucleic acid (mRNA), but not calcitonin mRNA in vivo in the rat. Dominant role of 1,25-dihydroxyvitamin D. Endocrinology 1989; 125:275-80.
20. Naveh-Many T, Rahamimov R, Livni N, Silver J. Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 1995; 96:1786-93.
21. Karp H, Ketola M, Lamberg-Allardt C. Acute effects of calcium carbonate, calcium citrate and potassium citrate on markers of calcium and bone metabolism in young women. Br J Nutr 2009; 102:1341-7.
22. Kanesaka Y, Tokunaga H, Iwashita K, Fujimura S, Naomi S, Tomita K. Endothelin receptor antagonist prevents parathyroid cell proliferation of low calcium diet-induced hyperparathyroidism in rats. Endocrinology 2001; 142:407-13.
23. Willett W, Sampson L, Stampfer M, Rosner B, Bain C, Witschi J, et al. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985; 122:51-65.
24. Salvini S, Hunter D, Sampson L, Stampfer M, Colditz G, Rosner B, et al. Food-based validation of a dietary questionnaire: the effects of week-to-week variation in food consumption. Int J Epidemiol 1989; 18:858-67.
25. Rimm E, Stampfer M, Colditz, GA, Chute C, Litin L, Willett W. Validity of self-reported waist and hip circumference in men and women. Epidemiology 1990; 1:466-73.
26. Wolf A, Hunter D, Colditz G, Manson J, Stampfer M, Corsano K, et al. Reproducibility and validity of a self-administered physical activity questionnaire. Int J Epidemiol 1994; 23:991-9.
27. Colditz GA, Martin P, Stampfer MJ, Willett WC, Sampson L, Rosner B, et al. Validation of questionnaire information on risk factors and disease outcomes in a prospective cohort study of women. Am J Epidemiol 1986; 123:894-900.
28. Manson JE, Colditz GA, Stampfer MJ, Willett WC, Krolewski AS, Rosner B, et al. A prospective study of maturity-onset diabetes mellitus and risk of coronary heart disease and stroke in women. Arch Intern Med 1991; 151:1141-7.
29. Colditz GA, Stampfer MJ, Willett WC, Stason WB, Rosner B, Hennekens CH, et al. Reproducibility and validity of self-reported menopausal status in a prospective cohort study. Am J Epidemiol 1987; 126:319-25.
30. Lundgren E, Rastad J, Thrufjell E, Akerström G, Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997; 121:287-94.
31. Kao P, van Heerden J, Grant C, Klee G, Khosla S. Clinical performance of parathyroid hormone immunometric assays. Mayo Clin Proc 1992; 67:637-45.
32. Ljunghall S, Larsson K, Lindh E, Lindqvist U, Rastad J, Akerström G, et al. Disturbance of basal and stimulated serum levels of intact parathyroid hormone in primary hyperparathyroidism. Surgery 1991; 110:47-53.
33. Rutledge R, Stiegel M, Thomas C Jr, Wild R. The relation of serum calcium and immunoparathormone levels to parathyroid size and weight in primary hyperparathyroidism. Surgery 1985; 98:1107-12.
34. Norman J, Goodman A, Politz D. Calcium, parathyroid hormone, and vitamin D in patients with primary hyperparathyroidism: normograms developed from 10,000 cases. Endocrine Practice 2011; 17:384-94.
35. Melton LJ. The epidemiology of primary hyperparathyroidism in North America. J Bone Miner Res 2002; 17(suppl 2):N12-7.
36. Wermers RA, Khosla S, Atkinson EJ, Achenbach SJ, Oberg AL, Grant CS, et al. Incidence of primary hyperparathyroidism in Rochester, Minnesota, 1993-2001: an update on the changing epidemiology of the disease. J Bone Miner Res 2006; 21:171-7.
37. Miller BS, Dimick J, Wainess R, Burney RE. Age- and sex-related incidence of surgically treated primary hyperparathyroidism. World J Surg 2008; 32:795-9.
38. Dent CE, Hartland BV, Hicks J, Sykes ED. Calcium intake in patients with primary hyperparathyroidism. Lancet 1961; 2:336-8.
39. Insogna KL, Mitnick ME, Stewart AF, Burtis WJ, Mallette LE, Broadus AE. Sensitivity of the parathyroid hormone-1,25-dihydroxyvitamin D axis to variations in calcium intake in patients with primary hyperparathyroidism. N Engl J Med 1985; 313:1126-30.
40. Jorde R, Szumlas K, Haug E, Sundsfjord J. The effects of calcium supplementation to patients with primary hyperparathyroidism and a low calcium intake. Eur J Nutr 2002; 41:258-63.
41. Locker FG, Silverberg SJ, Bilezikian JP. Optimal dietary calcium intake in primary hyperparathyroidism. Am J Med 1997; 102:543-50.
42. Shelby H. Age and sex-related incidence of primary hyperparathyroidism. World J Surg 2008; 32:800.